A Novel Classifier Based on Urinary Proteomics for Distinguishing between Benign and Malignant Ovarian Tumors

ABSTRACT: Preoperative differentiation of benign and malignant tumor types is critical for providing individualized treatment interventions to improve prognosis of patients with ovarian cancer. High-throughput proteomics analysis of urine samples was performed to identify reliable and non-invasive biomarkers that could effectively discriminate between the two ovarian tumor types.

ORGANISM(S): Homo Sapiens

SUBMITTER: Maowei Ni  

PROVIDER: PXD027695 | iProX | Wed Aug 04 00:00:00 BST 2021

REPOSITORIES: iProX